Glossary
More terms are explained in the adrreports.eu Glossary
Adverse Drug Reaction Report (Adrr)
The adrreports.eu portal provides public access to reports of suspected side effects submitted to the EudraVigilance system by national medicines regulatory authorities and pharmaceutical companies that hold marketing authorisations for medicines in the European Economic Area (EEA).
see: Adrreports.eu
Concomitant
Synonym for "accompanying". A descendant of Latin concomitari ("to accompany") and ultimately of "comes," the Latin word for companion.
source: Merriam Webster Dictionary
Drug
Synonym for Medicine as stated on Adrreports.eu: "Centrally authorised medicine or non-centrally authorised medicine"
"For centrally authorised medicines, access to reports is granted both by the name of the medicine or the name of the active substance. For non-centrally authorised medicines, access is granted based on the name of the active substance only."
As an example: the most reported substance we find in the database is Tozinameran, Comirnaty is the product it is used in, BioNTech/Pfizer-vaccin is the drug that would be administered.
_see: Adrreports.eu (EN)
Drug List
Information that shows characterisation of ‘Drug Role’, defined as suspect, interacting, concomitant or drug not administered. Based on this data element, 2 different ‘Drug’ (medicines) lists will be created, for suspect and interacting drugs and for concomitant or drug not administered. Reported medicinal product, displayed as recoded against the Extended EudraVigilance Medicinal Product Dictionary for centrally authorised products (for non-centrally authorised products, only the recoded substance will be displayed where reported). Substance / Specified Substance Name, displayed as recoded against the Extended EudraVigilance Medicinal Product Dictionary (if not, it will be displayed as reported). Indication of the medicinal product described as MedDRA Preferred Term. ‘Duration of Drug Administration’, as reported or based on ‘Drug Administration Start Date’ and ‘End Date’, Dose of the medicine and Route of administration of the medicine.
source: Web Report User Guide
EMA
Abbreviation for "European Medicine Agency".
"The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). It began operating in 1995. The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU."
source: EMA website
EudraVigilance
"The system for managing and analysing information on suspected adverse reactions to medicines which have been authorised or being studied in clinical trials in the European Economic Area (EEA). The European Medicines Agency (EMA) operates the system on behalf of the European Union (EU) medicines regulatory network."
source: EMA Website, EudraVigilance
Line listing
Data downloaded from the EudraVigilance webpage.
"The data and information provided at substance level is in the form of an electronic Reaction Monitoring Report (eRMR) containing aggregated data and a line listing with details of the individual cases. Users are also able to retrieve Individual Case Safety Report (ICSRs) forms accessible through the line listing."
see: EudraVigilance User Manual Marketing Authorisation Holders
Local number
The local number is the unique identifier also known as "Case Identifier format" as stated on page 89, #12 of the EU Individual Case Safety Report (ICSR)¹ Implementation Guide. It consists of
"Country code" followed by a dash, "organisation ID or name" followed by a dash and "local system number"
f.i.
EU-EC-2950025
In the public EMA database, Country code has been replaced by EU and organisation ID by EC (abbr. for European Commission) for all the reports.
mdbook
A tool used for generating documentation from markdown files. mdbook documentation website
Postgresql
The database system we use. PostgreSQL website
Report
Used throughout this documentation as synonym for ICSR or Individual Case Safety Report.
"Used for reporting to the EudraVigilance database suspected adverse reactions to a medicinal product that occur in a single patient at a specific point in time"
see: EU Individual Case Safety Report (ICSR)¹ Implementation Guide
SQL
"A domain-specific language used in programming and designed for managing data held in a relational database management system (RDBMS), or for stream processing in a relational data stream management system (RDSMS). It is particularly useful in handling structured data, i.e., data incorporating relations among entities and variables."
source: Wikipedia
Drug List
Information that shows characterisation of ‘Drug Role’, defined as suspect, interacting, concomitant or drug not administered. Based on this data element, 2 different ‘Drug’ (medicines) lists will be created, for suspect and interacting drugs and for concomitant or drug not administered. Reported medicinal product, displayed as recoded against the Extended EudraVigilance Medicinal Product Dictionary for centrally authorised products (for non-centrally authorised products, only the recoded substance will be displayed where reported). Substance / Specified Substance Name, displayed as recoded against the Extended EudraVigilance Medicinal Product Dictionary (if not, it will be displayed as reported). Indication of the medicinal product described as MedDRA Preferred Term. ‘Duration of Drug Administration’, as reported or based on ‘Drug Administration Start Date’ and ‘End Date’, Dose of the medicine and Route of administration of the medicine.
source: Web Report User Guide